IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy

Journal:

Immunity

Published:

2025-11-21

DOI:

10.1016/j.immuni.2025.10.024

Affiliations:

11

Authors:

20

Go to article

Institutions	Authors	Share
Stanford University School of Medicine, United States of America (USA)	16.166667 16.166667	0.81
Stanford Cancer Center, United States of America (USA)	1.500000	0.08
UCLA Health, United States of America (USA)	1.166667	0.06
University of California, Los Angeles (UCLA), United States of America (USA)	0.833333	0.04
Parker Institute for Cancer Immunotherapy, United States of America (USA)	0.333333	0.02

Interested in Oncology and Carcinogenesis?